BRAIN Biotech AG
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BRAIN Biotech AG is a leading European specialist in industrial biotechnology, focused on developing bio-based products and solutions. The company provides end-to-end services encompassing the discovery, development, and production of specialty enzymes, proteins, and microbial production strains. Through its contract research and development (R&D) model, BRAIN Biotech leverages an advanced technology portfolio to deliver tailor-made biosolutions for industrial clients, primarily in the food and life sciences sectors. These customized solutions help customers overcome complex scientific challenges, creating innovative and sustainable products and processes that enhance their commercial success and competitive market advantages.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for BRAIN Biotech AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-23 08:30 |
Board/Management Information
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
|
English | 13.4 KB | |
| 2025-06-23 08:05 |
Share Issue/Capital Change
Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billio…
|
English | 22.4 KB | |
| 2025-05-28 07:30 |
Earnings Release
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
|
English | 20.0 KB | |
| 2025-05-28 00:00 |
Interim Report
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2024 bis zum 31.03…
|
German | 99.2 KB | |
| 2025-05-28 00:00 |
Interim Report
Half-yearly financial report 2024/2025
|
English | 364.5 KB | |
| 2025-05-21 10:00 |
M&A Activity
BRAIN Biotech announces buy-out of minorities, new continental European product…
|
English | 16.2 KB | |
| 2025-05-19 11:23 |
Report Publication Announcement
|
English | 4.1 KB | |
| 2025-05-19 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
|
German | 5.8 KB | |
| 2025-05-19 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
|
German | 5.8 KB | |
| 2025-04-30 17:54 |
Earnings Release
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
|
English | 6.0 KB | |
| 2025-03-19 16:45 |
Post-Annual General Meeting Information
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
|
English | 14.6 KB | |
| 2025-03-18 16:45 |
Post-Annual General Meeting Information
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
|
English | 14.6 KB | |
| 2025-03-04 11:25 |
Director's Dealing
BRAIN Biotech AG: Michael Schneiders, buy
|
English | 6.0 KB | |
| 2025-03-03 11:25 |
Director's Dealing
BRAIN Biotech AG: Michael Schneiders, buy
|
English | 6.0 KB | |
| 2025-02-27 07:30 |
Earnings Release
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growt…
|
English | 20.8 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
